...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Data Expected September 2019 for BETonMACE Phase 3 Cardiovascular Outcomes Trial for Apabetalone

Free
AGORACOM NEWS FLASH

BREAKING: American Creek Announces Additional $1,000,000 Strategic Financing with Eric Sprott

  • Intends to expand the non-brokered private placement in order to include an additional $1,000,000 investment by Eric Sprott
  • Darren Blaney, President & CEO of American Creek stated: “We welcome Mr. Sprott’s further support and additional significant contribution. We greatly appreciate not only his endorsement but also his enthusiasm for the future potential of American Creek’s vision and projects.

Hub On AGORACOM / Read Release

Message: AGM 2018 - Masila Notes

GAC

i remember a discussion at the time about this as to how odd I found that comment (I believe made by DM). At least I recall I tried to have one on this board. 

If half were on a placebo, it would make sense that half of the test subjects weren’t getting the great results they wanted. If that is the case (and they remain blinded), then why would ALL of them want to stay on “the treatment”. Particularly because half of “the treatment”’was sugar pills. 

If a subject has a mace event, was there treatment discontinued? And if so, why would they want to stay in the treatment after that, when the study was to reduce the likelyhood of reducing incidents of mace. If their treatment was continued after the mace event, then same question, why would ALL the subjects who had a mace event unanimously want to continue “the treatment”

What are the odds of thousands of subjects ALL wanting to stay on “the treatment” after that. Has any one of us ever seen that large a group of elderly people THAT content with their treatment?, any kind of treatment?

It was a very odd comment in my opinion. 

DYODD

Regards

DND

Share
New Message
Please login to post a reply